The advance purchase agreement with Medicago was awarded in November 2020, and there was a firm commitment for 20 million doses to be delivered by the end of December 2021, as well as optional additional doses of up to 56 million.
The contract was later amended. Because the Health Canada authorization was received in February 2022, the contract was amended to change the delivery of the 20 million firm doses to the end of 2022.